Search Results - "Cheuk, Adam"

Preclinical Evaluation of the FGFR-Family Inhibitor Futibatinib for Pediatric Rhabdomyosarcoma.

Authors: Wu, Jerry T. Cheuk, Adam Isanogle, Kristine et al.

Source: Cancers. Aug2023, Vol. 15 Issue 16, p4034. 17p.

An optimized bicistronic chimeric antigen receptor against GPC2 or CD276 overcomes heterogeneous expression in neuroblastoma.

Authors: Tian, Meijie Cheuk, Adam T. Wei, Jun S. et al.

Source: Journal of Clinical Investigation. 8/15/2022, Vol. 132 Issue 16, p1-17. 17p.

Targeting Wild-Type and Mutationally Activated FGFR4 in Rhabdomyosarcoma with the Inhibitor Ponatinib (AP24534).

Authors: Li, Samuel Q. Cheuk, Adam T. Shern, Jack F. et al.

Source: PLoS ONE. Oct2013, Vol. 8 Issue 10, p1-9. 9p.

Anti-tumor immunity in a model of acute myeloid leukemia.

Authors: Cheuk, Adam T. C. Wells, James W. Chan, Lucas et al.

Source: Leukemia & Lymphoma. Mar2009, Vol. 50 Issue 3, p447-454. 8p. 4 Graphs.

Role of 4-1BB:4-1BB ligand in cancer immunotherapy.

Authors: Cheuk, Adam T. C. Mufti, Ghulam J. Guinn, Barbara-ann

Source: Cancer Gene Therapy. Mar2004, Vol. 11 Issue 3, p215-226. 12p.

Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models.

Authors: Taylor VI, James G. Cheuk, Adam T. Tsang, Patricia S. et al.

Source: Journal of Clinical Investigation. Nov2009, Vol. 119 Issue 11, p3395-3407. 13p. 1 Color Photograph, 1 Diagram, 3 Charts, 7 Graphs.

Development of a whole cell vaccine for acute myeloid leukaemia.

Authors: Cheuk, Adam T. C. Chan, Lucas Czepulkowski, Barbara et al.

Source: Cancer Immunology, Immunotherapy. Jan2006, Vol. 55 Issue 1, p68-75. 8p.

CAR-T cell expansion platforms yield distinct T cell differentiation states.

Authors: Song, Hannah W. Prochazkova, Michaela Shao, Lipei et al.

Source: Cytotherapy (Elsevier Inc.). Jul2024, Vol. 26 Issue 7, p757-768. 12p.

CLPTM1L Promotes Growth and Enhances Aneuploidy in Pancreatic Cancer Cells.

Authors: Jinping Jia Bosley, Allen D. Thompson, Abbey et al.

Source: Cancer Research. 5/15/2014, Vol. 74 Issue 10, p2785-2795. 11p.

Massively Parallel Sequencing Reveals an Accumulation of De Novo Mutations and an Activating Mutation of LPAR1 in a Patient with Metastatic Neuroblastoma.

Authors: Wei, Jun S. Johansson, Peter Chen, Li et al.

Source: PLoS ONE. Oct2013, Vol. 8 Issue 10, p1-1. 1p.

Targeted antibody-drug conjugates for rhabdomyosarcoma and other FGFR4-expressing cancers.

Authors: Tian M Jia K Wu JT et al.

Source: Cell reports. Medicine [Cell Rep Med] 2026 Jul 14, pp. 102922. Date of Electronic Publication: 2026 Jul 14.

Publication Type: Journal Article

Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med Subsets: MEDLINE

CAR T-cells targeting FGFR4 and CD276 simultaneously show potent antitumor effect against childhood rhabdomyosarcoma.

Authors: Tian M Wei JS Cheuk AT et al.

Source: Nature communications [Nat Commun] 2024 Jul 23; Vol. 15 (1), pp. 6222. Date of Electronic Publication: 2024 Jul 23.

Publication Type: Journal Article; Research Support, N.I.H., Intramural; Research Support, N.I.H., Extramural

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma.

Authors: Tian M Wei JS Shivaprasad N et al.

Source: Cell reports. Medicine [Cell Rep Med] 2024 May 21; Vol. 5 (5), pp. 101586. Date of Electronic Publication: 2024 May 09.

Publication Type: Published Erratum

Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med Subsets: MEDLINE; PubMed not MEDLINE

Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma.

Authors: Tian M Wei JS Shivaprasad N et al.

Source: Cell reports. Medicine [Cell Rep Med] 2023 Oct 17; Vol. 4 (10), pp. 101212. Date of Electronic Publication: 2023 Sep 28.

Publication Type: Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med Subsets: MEDLINE

A stem cell epigenome is associated with primary nonresponse to CD19 CAR T cells in pediatric acute lymphoblastic leukemia.

Authors: Masih KE Gardner RA Chou HC et al.

Source: Blood advances [Blood Adv] 2023 Aug 08; Vol. 7 (15), pp. 4218-4232.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

FGFR4-Targeted Chimeric Antigen Receptors Combined with Anti-Myeloid Polypharmacy Effectively Treat Orthotopic Rhabdomyosarcoma.

Authors: Sullivan PM Kumar R Li W et al.

Source: Molecular cancer therapeutics [Mol Cancer Ther] 2022 Oct 07; Vol. 21 (10), pp. 1608-1621.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE

Immunohistochemical detection of PAX-FOXO1 fusion proteins in alveolar rhabdomyosarcoma using breakpoint specific monoclonal antibodies.

Authors: Azorsa DO Bode PK Wachtel M et al.

Source: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2021 Apr; Vol. 34 (4), pp. 748-757. Date of Electronic Publication: 2020 Dec 09.

Publication Type: Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 8806605 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0285 (Electronic) Linking ISSN: 08933952 NLM ISO Abbreviation: Mod Pathol Subsets: MEDLINE

Synthetic lethal screen identifies NF-κB as a target for combination therapy with topotecan for patients with neuroblastoma.

Authors: Tsang PS Cheuk AT Chen QR et al.

Source: BMC cancer [BMC Cancer] 2012 Mar 21; Vol. 12, pp. 101. Date of Electronic Publication: 2012 Mar 21.

Publication Type: Journal Article; Research Support, N.I.H., Intramural

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Systematic proteome analysis identifies transcription factor YY1 as a direct target of miR-34a.

Authors: Chen QR Yu LR Tsang P et al.

Source: Journal of proteome research [J Proteome Res] 2011 Feb 04; Vol. 10 (2), pp. 479-87. Date of Electronic Publication: 2010 Dec 23.

Publication Type: Journal Article; Research Support, N.I.H., Intramural

Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101128775 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-3907 (Electronic) Linking ISSN: 15353893 NLM ISO Abbreviation: J Proteome Res Subsets: MEDLINE

Screening a panel of drugs with diverse mechanisms of action yields potential therapeutic agents against neuroblastoma.

Authors: Gheeya JS Chen QR Benjamin CD et al.

Source: Cancer biology & therapy [Cancer Biol Ther] 2009 Dec; Vol. 8 (24), pp. 2386-95. Date of Electronic Publication: 2009 Dec 27.

Publication Type: Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101137842 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1555-8576 (Electronic) Linking ISSN: 15384047 NLM ISO Abbreviation: Cancer Biol Ther Subsets: MEDLINE